PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results....
PRINCETON, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“P...
Publisher
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
PRINCETON, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“P...
Source route
Continue on pdsbiotech.com
Leave the platform to read the original full article on the publisher site.
Source: PDS Biotechnology
Scope: Industry
Related coverage
More related coverage
CANOPY GROWTH ANNOUNCES STORZ & BICKEL EXECUTIVE TRANSITION
David Männer appointed Managing Director Jürgen Bickel, who co-founded and built Storz & Bickel into...
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summ...
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the disc...